Trial intelligence / Profile preview

Plasma kinetics of tablet vs liquid 6-mercaptopurine in childhood ALL

2013-001236-21Phase 4Completed

Sponsor
Kjeld Schmiegelow
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of mercaptopurine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Kjeld Schmiegelow. Primary endpoint: Tmax. Started May 2013; status: completed.

02

Drugs

mercaptopurine
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on 2013-001236-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001236-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call